• 2006

Company Description

Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.

Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women’s health disorders with unmet medical needs. The Company’s initial focus is in overlooked therapeutic areas that affect millions of women each year. These areas include gynecologic and aromatase-meditated conditions such as endometriosis and uterine fibroids.